Strobeck Matthew 4

Accession 0000905148-24-001615

CIK 0001439725other

View on SEC.gov Company Profile

Filed

May 22, 8:00 PM ET

Accepted

May 23, 7:15 PM ET

Size

21.7 KB

Accession

0000905148-24-001615

Insider Transaction Report

Form 4

Period: 2024-05-21

BIODESIX INCBDSX

Strobeck Matthew

Director

Transactions

Exercise/Conversion
Common Stock
2024-05-23+295,680→ 2,570,879 total(indirect: By LLC)
Exercise/Conversion
Series A Non-Voting Convertible Preferred Stock
2024-05-23−1,304→ 0 total(indirect: By Birchview Capital Separately Managed Account)
→ Common Stock (52,160 underlying)
Exercise/Conversion
Series A Non-Voting Convertible Preferred Stock
2024-05-23−7,392→ 0 total(indirect: By LLC)
→ Common Stock (295,680 underlying)
Exercise/Conversion
Common Stock
2024-05-23+52,160→ 85,673 total(indirect: By Birchview Capital Separately Managed Account)
Award
Restricted Stock Units
2024-05-21+53,726→ 53,726 total
→ Common Stock (53,726 underlying)
Award
Stock Options (Right to Buy)
2024-05-21+37,050→ 37,050 total
Exercise: $1.57Exp: 2034-05-20→ Common Stock (37,050 underlying)

Holdings

Common Stock
2,542,928
Common Stock
(indirect: By UTMA Account)
119,003
Common Stock
(indirect: By UTMA Account)
119,003
Common Stock
(indirect: By UTMA Account)
119,003
Common Stock
(indirect: By UTMA Account)
119,003
Common Stock
(indirect: By LLC)
40,665

Footnotes (8)

[F1]The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024.
[F2]The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
[F3]The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
[F4]The Reporting Person is an affiliate of Clajer Capital LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
[F5]Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Common Stock.
[F6]These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.
[F7]Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer.
[F8]This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.

Documents

1 file

4
form4.xmlPrimary

Issuer

BIODESIX INC

CIK 0001439725

→

Entity typeother

Related Parties

filerCIK 0001377832

Filing Metadata

Form type: 4
Filed: May 22, 8:00 PM ET
Accepted: May 23, 7:15 PM ET
Size: 21.7 KB

View on SEC.gov